Summary Sprague-Dawley rats were given eight weekly subcutaneous injections of 1,2-dimethylhydrazine (DMH) or of vehicle then were sacrificed at 1, 5 or 24 weeks after the last injection of DMH. The locations of pre-existing aggregates of lymphoid nodules (ALNs), the location and multiplicity (size) of aberrant crypt foci (ACF), and the locations of tumours in the colon were determined. A trimodal distribution of pre-existing ALNs along the length of the colon was significantly correlated with the timodal distribution of DMH-induced adenocarcinomas (ACs ALNs are normal features in the colon of rats that have not been exposed to a colon carcinogen and are consistently found at three distinct sites along the length of the colon of Sprague-Dawley rats (Nauss et al., 1984; Hardman and Cameron, 1994) . Solitary lymphoid nodules are rarely observed outside the limits of one of these three sites of ALNs in the rat colon. This unique anatomical distribution of lymphoid nodules in the rat allows study of the role of the lymphoid nodules on colorectal carcinogenesis which is not possible in species in which individual lymphoid nodules are more uniformly distributed in the colon.
This report concerns the distribution of aggregates of lymphoid nodules (ALNs), of aberrant crypt foci (ACF) and of tumours along the length of the colon in carcinogentreated rats. The results of the study provide information about the role that ALNs and ACF play in determination of the distribution of colonic adenocarcinomas (ACs) in rats.
ALNs are normal features in the colon of rats that have not been exposed to a colon carcinogen and are consistently found at three distinct sites along the length of the colon of Sprague-Dawley rats (Nauss et al., 1984; Hardman and Cameron, 1994) . Solitary lymphoid nodules are rarely observed outside the limits of one of these three sites of ALNs in the rat colon. This unique anatomical distribution of lymphoid nodules in the rat allows study of the role of the lymphoid nodules on colorectal carcinogenesis which is not possible in species in which individual lymphoid nodules are more uniformly distributed in the colon.
The findings from several reports (Nauss et al., 1984; Martin et al., 1986; Shamsuddin and Hogan, 1984; Bland and Britton, 1984) have indicated that the majority of carcinogeninduced ACs in the colon of rats occur in close spatial association with each ALN site. In addition, it has been reported that a large proportion of these ACs originate as microscopic, endophytic AC within the ALN . Furthermore, the microscopic, endophytic ACs found within the ALNs showed no evidence of an adenomatous precursor, suggesting that these endophytic ACs arose de novo . It was concluded that ALNs are promotional to development of microscopic, endophytic ACs in the rat and to development of ACs in general.
In a recent report addressing the hypothesis that ACF are carcinogen-induced premalignant lesions in the colon of rats (Caderni et al., 1995) , the authors examined morphological parameters and mucin production in ACF of whole colons from carcinogen-treated rats to assess the putative premalignant potential of the ACF. The authors found no statistically significant association between either the number of ACF or the size of ACF and the presence of tumours in the colon. Staining and counting of aggregates of lymphoid nodules and of aberrant crypt foci Tannin, leached from the corkboard onto which the colon was pinned, differentially stained the tissue and aided visualisation of the ALNs using transillumination and a dissecting microscope (Figure 1 ). The identification of ALNs using a dissecting microscope was confirmed using histological sections through the ALNs. The distance from the anus to the distal end and to the proximal end of each ALN was measured and recorded. All distance measurements were eventually normalised to per cent distance from the anus to the ileum. This normalisation procedure adjusts for normal deviations in the large bowel length between individual rats and for shrinkage due to fixation. Only ALNs from non-DMH-treated rats were used in the statistical assessment of the ALN distribution because a correlation of tumour distribution with the distribution of pre-existing ALNs was sought to determine if ALNs had a promotional role in the carcinogenesis process.
Methylene blue stain [0.5% in phosphate-buffered saline (PBS), pH 7.1] was used to aid visualisation of the ACE. The colon was removed from the cork and placed luminal side up into a Petri dish and flooded with stain. After about 30 min, excess stain was rinsed off with PBS. The colon was placed into a Petri dish which had a centimetre scale marked on the bottom, then placed under a stereomicroscope (30 x magnification) and transillumination was used for scoring of ACE. The number and size classification of ACF in each 1 cm along the length of the colon were counted and recorded.
Statistical analysis
The SPSSX plus statistical package (Nie et al., 1983) was used for statistical evaluations. The statistical tests used included two-way analysis of variance (ANOVA), one-way ANOVA, and Student-Newman-Keuls multiple range tests to determine significant differences between group means. Linear regression analysis was used to determine correlation between variables.
Results
Location of ALNs along the length of the colon ALN were present at one or more of three distinct sites in the colon of each rat. Specifically, a total of 20 non-DMHtreated rats were scored for distribution of ALN. All 20 rats had a visible ALN in the distal colon (located at 19.2 + 0.4% of the distance from the anus), 12 had a visible ALN in the mid-colon (located at 53.9 + 1.7%) and 17 had a visible ALN in the proximal colon (located at 88.3+1.5%). The mean total number of ACF per rat in groups of rats killed at either 1 or 5 weeks after the last of eight weekly injections of DMH was subjected to ANOVA. The mean number of ACF per rat at 1 week after the last DMH injection was significantly less than at 5 weeks after the last DMH injection (228+39 vs 380+55, P < 0.05, n = 4 rats per group). This significant increase in ACF between 1 and 5 weeks after the last DMH injection indicates that the total number of ACF continued to increase in the absence of additional carcinogen adminstration. Correlation analyses between (1) the distribution of ACF at I or at 5 weeks after the last DMH injection: (2) the distribution of tumours at 24 weeks after the last DMH injection; and (3) the distribution of pre-existing ALN along the length of the colon Figure 2c illustrates the distribution of adenomas and the distribution of AC along the length of the colon scored 24 weeks after the last of the eight weekly injections of DMH (n = 335 tumours in 402 rats.) Histological examination identified only 4.8% of all colon tumours as adenomas. There were three peaks in the distribution of AC along the length of the colon. The numerical distribution of adenomas along the length of the colon was not the same as the distribution of AC; specfically, 81% (13/16) of the adenomas were located between the sites of the distal two ALN but most of the ACs were located within the confines of the three sites of ALNs. Table I presents the data on the distribution of 2640 ACF (from eight rats) and 335 tumours (from 402 rats) along the length of the colon of the DMH-treated rats. Linear regression analyses were performed on the data in Table I to determine if the numerical distribution of ACF (scored at 1 week or 5 weeks after the last DMH injection) correlated significantly with the numerical distribution of either adenomas or of ACs along the length of the colon (scored at 24 weeks after the last injection of DMH). The results of linear regression analyses indicated that the number of ACF along the length of the colon (counted at either 1 week or S weeks after the last DMH injection) did not correlate significantly (P <0.05) with the number of adenomas or with the number of AC found along the length of the colon at 24 weeks after the last DMH injection.
To assess further the relationships between the distributions of ACF, ACs (of two morphological types, either polypoid or sessile) and ALNs along the length of the colon of DMH-treated Sprague -Dawley rats, the ACF data 24 weeks after the last eight weekly injections of DMH. The numbers of different-sized ACF were scored in two groups with four rats in each group; a total of 2640 ACF were counted. The per cent of the total number of adenomas and of AC in DMH-treated rats is plotted as a function of distance from the anus to ileum (data from Table II) indicate: (1) that the distribution of ALN found at the time of sacrifice of the DMH-treated rats in the previous study (Nauss et al., 1984) was significantly correlated (P<0.05) with the distribution of the more numerous sessile ACs but was not significantly correlated (P>0.05) with the distribution of the less numerous polypoid ACs; and (2) that the number of ACF (found at either 1 week or 5 weeks after the last exposure to DMH) did not correlate (P>0.05) with the distributions of either sessile or polypoid ACs along the length of the colon. The finding from the regression analyses between the two sets of experimental data must be tempered by the fact that the data of Nauss et al. (1984) were obtained on rats given DMH via intragastric gavage whereas the ACF data are from rats given DMH via subcutaneous injections. This and other differences between experiments makes the analyses less stringent than the analyses of data presented in Table I (data collected using the same protocol).
Discussion
A main finding of this study is that the distribution of ACF along the length of the colon of carcinogen (DMH)-treated rats is not the same as the distribution of carcinogen-induced ACs which form in rats; thus, neither the number nor the size of ACF could be expected to directly predict the occurrence of AC. The lack of correlation between ACF and AC and the significant correlation between ALN and AC indicates that it is the enhancement of carcinogenesis due to the presence of ALN, not the numbers or distribution pattern of ACF, which is the main determinant of the distribution of ACs in the carcinogen-treated rats. The main reasons why the numbers and/or sizes of ACF have not been shown to predict the incidence of colonic AC reliably may be that the promotional effect of the ALNs is quite specific to the formation of endophytic ACs and/or that the promotional effect of the ALNs is localised to a relatively small proportion of the total luminal surface area of the colon of rats where ALNs occur. In this regard, it has been reported that about 70% of rat colonic ACs are endophytic or sessile ACs (Nauss et al., 1984; Martin et al., 1986; Hardman and Cameron, 1994) that are found in association with the small areas of ALNs. It is worth noting that visible ALNs were observed in the (1984) were collected from 3 cm length segments. The mean (in per cent of the total distance from the anus to the iluem) of each segment is reported in this 897 proximal quarter of the colon in the majority of the rats, but that none of the 2640 ACF were found in this proximal quarter of the colon at either 1 or 5 weeks after the last DMH injection. As the distribution of ACF was not scored in the proximal portion of the colon at 24 weeks after the last DMH injection, it cannot be claimed with certainty that no ACF ever arise in this region of the colon. However, if an ACF arises in this segment of the colon it must be considered an extremely rare event. Thus, it seems highly unlikely that ACs which do form in this proximal quarter of the colon could have arisen via an ACF precursor pathway. The likely explanation for AC genesis in this proximal segment of the colon is via the de novo pathway of AC formation.
If one assumes, for the sake of discussion, that ACF are the sole precursor lesions to ACs, then one can calculate the expected conversion of ACF to ACs. For example, based on the data in Table I , the average number of ACF per rat at 5 weeks was 380; this compares with an average of 0.79 ACs per rat at 24 weeks after the last DMH injection. Thus, only a small percentage (0.2%) of the ACF present at 5 weeks could have evolved into ACs present at 24 weeks. Similar calculations done at about 35% of the distance from the anus to the ileum results in an even lower percentage of possible conversions of ACF to ACs (0.06%) in the area between the two distal ALNs. This latter estimate of possible conversion of putative premalignant foci to malignant foci in an area of the colon without putative promotion effects from the lymphatic nodules compares with an estimate of 0.02% for conversion of carcinogen-induced premalignant aberrant liver foci to malignant tumours in the rat liver (Williams and Watanbe, 1978) . Based on these calculations, it may be concluded that progression from a carcinogen-altered foci to a malignant tumour is rare both in the liver and in the colon of rats. However, the calculated conversion of ACF to ACs (based on the data in Table I ) is 4-to 5-fold higher in the sites of the two distal ALNs in the rat colon than in the area between the two distal ALN sites. Thus, ALNs are either promotional to the rare conversion of ACF to become ACs and/or are promotional to the de novo formation of ACs. These two possibilities are not mutually exclusive in the distal colon, but either possibility indicates a promotional role for ALNs in colon carcinogenesis. Calculation of the potential ACF to AC conversion percentages in the proximal quarter of the colon was not possible as no ACF could be found in the proximal quarter of the colon.
The above findings are not intended to convey to the reader that measurement of the numbers, size and distribution of ACF in rats is of little or no value as a biomarker of colon carcinogenesis. The number of ACF found in the colon is undoubtedly an indicator of exposure to the known colon carcinogens so far tested (McLellan and Bird, 1988; Tudek et al., 1989) , and in this regard ACF can be said to reflect risk of colon cancer. But because neither the number nor the size of ACF has proved a significant predictor of AC formation along the length of the colon in the rat model system (this report) or in the mouse (Carter et al., 1994) , the use of the total numbers or size of ACF in the colon of rats is not necessarily a valid indicator of the risk of malignant colon cancer. Indeed, there are now several reports from independent studies which fail to confirm numbers of ACF as a reliable indicator of cancer risk throughout the colon of rats (Hardman et al., 1991; Caderni et al., 1995; Thorup et al., 1994) .
In conclusion, the results from the present and from past reports (Nauss et al., 1984; Shimamoto and Vollmer, 1987; Martin et al., 1986; Hardman and Cameron, 1994; Carter et al., 1994; Shamsuddin and Hogan, 1984) indicate a strong promotional role for lymphoid nodules in colon carcinogenesis. That ACs can arise along a pathway that does not pass through an ACF stage seems highly likely in the proximal quarter of the colon of the rat (data in this report). It also seems that there is no direct proof that any aberrant crypt foci progress to become malignant cancer, nor is there direct proof to the contrary. The question remains: do ACF represent true premalignant lesions which on rare occasion progress via a multistep process to become ACs or do ACF and colon AC represent end points of two parallel but independent pathways resulting as a consequence of a common colon cancer initiation (Thorup et al., 1994; Jen et al., 1994; Smith et al., 1994; Yamashita et al., 1995; Pretlow, 1995) ? Serial observations using endoscopic procedures on humans and on animal models followed by terminal histology may eventually provide direct evidence on the fate of ACE. Regardless of the outcome, the fact remains that the numbers and the multiplicity (size) of ACF are currently being used as biomarkers of colon cancer risk (Lam and Zhang, 1991; Periera and Khoury, 1991; O'Riordan et al., 1991; Wargovich et al., 1992; Rao et al., 1993; Zhang et al., 1992; Deschner et al., 1990; Pereira et al., 1994) but interpretation of the results of intervention studies that use ACF as biomarkers of efficacy of intervention must take into account the questionable value of ACF numbers and sizes as valid predictors of colon cancer risk.
